1st Total Artificial Heart Patient Discharged Home from Sentara Heart Hospital
63-Year-Old John Martino Looking Forward to Watching His 4 Grandchildren Grow Up
(firmenpresse) - TUCSON, AZ -- (Marketwire) -- 03/15/12 -- SynCardia Systems, Inc. (), manufacturer of the SynCardia temporary Total Artificial Heart, announced today that on March 7, Sentara Heart Hospital in Norfolk, VA, discharged its first Total Artificial Heart patient home using the Freedom® portable driver.
"We expect Mr. Martino to be able to exercise, visit with friends and family, and lead a relatively normal life now that he is home," said cardiologist Dr. John Herre, medical director of the Sentara Advanced Heart Failure Program.
John Martino, a 63-year-old grandfather of four, is the second patient to be implanted with the at Sentara and the first to be discharged from the hospital to wait for a matching donor heart at home. Sentara's first patient, who received the Total Artificial Heart on Oct. 26, 2011, was successfully transplanted on Jan. 3, 2012.
"Our goal with Total Artificial Heart patients is to make them as strong and healthy as possible while awaiting a heart transplant," said Dr. Michael McGrath, a cardiac surgeon at Sentara Heart Hospital. "Replacing the diseased heart with the Total Artificial Heart helps keep the body functioning close to normal."
Mr. Martino was first diagnosed with hypertension in his early 20s when the draft board rejected him for service in Vietnam. Since then, his heart health has continued to decline -- he's had . In need of a heart transplant and running out of time, Mr. Martino's doctors decided his heart was too damaged for a left ventricular assist device (LVAD). On Jan. 19, he was implanted with the Total Artificial Heart as a bridge to transplant.
Less than a month later, Mr. Martino's condition had stabilized and on Feb. 20, he was switched from the 418-pound "Big Blue" hospital driver to the 13.5 pound , the world's first wearable power supply for the SynCardia Total Artificial Heart. He was discharged from the hospital on March 7.
"I'm thankful to be here," said Mr. Martino, who is looking forward to sitting in his lounge chair and sleeping in his own bed. "I have four grandchildren and that's what I live for now. I want to be able to see them grow up. So the longer I can be around to do that, I'm thankful."
The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
from Sentara's press conference
from Sentara Heart Hospital
CAUTION - The Freedom® portable driver is an investigational device, limited by United States law to investigational use.
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart...
Like SynCardia on
Follow SynCardia on Twitter -
Connect with SynCardia on
Image Available:
Contact:
Don Isaacs
VP, Communications
(520) 955-0660
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.03.2012 - 12:30 Uhr
Sprache: Deutsch
News-ID 125172
Anzahl Zeichen: 0
contact information:
Town:
TUCSON, AZ
Kategorie:
Hospitals, Facilities and Providers
Diese Pressemitteilung wurde bisher 237 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"1st Total Artificial Heart Patient Discharged Home from Sentara Heart Hospital"
steht unter der journalistisch-redaktionellen Verantwortung von
SynCardia Systems, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
